The DOI matches its Crossref record; 135 of the 136 references it cites were found in a registry or an index.
p53 and E2f: partners in life and death
Abstract
During tumour development cells sustain mutations that disrupt normal mechanisms controlling proliferation. Remarkably, the Rb-E2f and MDM2-p53 pathways are both defective in most, if not all, human tumours, which underscores the crucial role of these pathways in regulating cell cycle progression and viability. A simple interpretation of the observation that both pathways are deregulated is that they function independently in the control of cell fate. However, a large body of evidence indicates that, in addition to their independent effects on cell fate, there is extensive crosstalk between these two pathways, and specifically between the transcription factors E2F1 and p53, which influences vital cellular decisions. This Review discusses the molecular mechanisms that underlie the intricate interactions between E2f and p53.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“E2F1 signals positive and negative feedback to p53.225”
From Census and evaluation of p53 target genes (2017) · cites this paper as [225]
Citations
Cites
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Network motifs: theory and experimental approaches
Alon, U. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2102 · Cited by 3,279
Live or let die: the cell's response to p53
Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,231
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Nakano, K., & Vousden, K. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00214-3 · Cited by 2,315
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Flagged first, then by citations
1 of the 136 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mutant p53: one name, many proteinsPreprint
Freed-Pastor, W. A., & Prives, C. L. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,290
Jansson, M., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,150
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Donehower, L. A., Soussi, T., Korkut, A., Liu, Y., Schultz, A., Cardenas, M., Li, X., Babur, Ö., Hsu, T., Lichtarge, O., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.001 · Cited by 724
The role of nuclear lamin B1 in cell proliferation and senescence
Shimi, T., Butin-Israeli, V., Adam, S. A., Hamanaka, R. B., Goldman, A. E., Lucas, C. A., Shumaker, D. K., Kosak, S. T., Chandel, N. S., & Goldman, R. D. (2011) · Genes & Development · doi:10.1101/gad.179515.111 · Cited by 547
The return of the nucleus: transcriptional and epigenetic control of autophagy
Füllgrabe, J., Klionsky, D. J., & Joseph, B. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3716 · Cited by 475
Hale, A. N., Ledbetter, D., Gawriluk, T. R., & Rucker, E. B. (2013) · Autophagy · doi:10.4161/auto.24273 · Cited by 343
Senescence from G2 arrest, revisited
Gire, V., & Dulić, V. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1000134 · Cited by 300
Exploiting replicative stress to treat cancer
Dobbelstein, M., & Sørensen, C. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4553 · Cited by 310
Khan, N., Downey, J., Sanz, J., Kaufmann, E., Blankenhaus, B., Pacis, A., Pernet, E., Ahmed, E. A., Cardoso, S., Nijnik, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.062 · Cited by 306
Microsporidian genome analysis reveals evolutionary strategies for obligate intracellular growthPreprint
Cuomo, C. A., Desjardins, C. A., Bakowski, M. A., Goldberg, J. M., Ma, A. T., Becnel, J. J., Didier, E. S., Fan, L., Heiman, D. I., Levin, J. Z., et al. (2012) · Genome Research · doi:10.1101/gr.142802.112 · Cited by 279
Stein, L. R., & Imai, S. (2014) · The EMBO Journal · doi:10.1002/embj.201386917 · Cited by 265
A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis.
Kracikova, M., Akiri, G., George, A., Sachidanandam, R., & Aaronson, S. A. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.155 · Cited by 261
Oncogene-induced senescence: the bright and dark side of the response
Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.07.013 · Cited by 257
The intersection between DNA damage response and cell death pathways.
Nowsheen, S., & Yang, E. S.-H. (2012) · PubMed · Cited by 219
Autophagy and the Cell Cycle: A Complex Landscape
Mathiassen, S. G., Zio, D. D., & Cecconi, F. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00051 · Cited by 214
E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis
Lizé, M., Pilarski, S. M., & Dobbelstein, M. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.188 · Cited by 213
Monti, S., Chapuy, B., Takeyama, K., Rodig, S. J., Hao, Y., Yeda, K. T., Inguilizian, H., Mermel, C. H., Currie, T., Doǧan, A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.014 · Cited by 215
Targeting the RB-pathway in Cancer Therapy
Knudsen, E. S., & Wang, J. Y. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0787 · Cited by 210
Transcriptional regulation of mammalian autophagy at a glance
Füllgrabe, J., Ghislat, G., Cho, D., & Rubinsztein, D. C. (2016) · Journal of Cell Science · doi:10.1242/jcs.188920 · Cited by 200
Multifaceted role of prohibitin in cell survival and apoptosis
Peng, Y., Chen, P., Ouyang, R., & Song, L. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1143-z · Cited by 195
20 years studying p53 functions in genetically engineered mice
Donehower, L. A., & Lozano, G. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2731 · Cited by 196
Clinical update on cancer: molecular oncology of head and neck cancer
Suh, Y., Amelio, I., Urbano, T. G., & Tavassoli, M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.548 · Cited by 195
Mitochondrial Stress Engages E2F1 Apoptotic Signaling to Cause Deafness
Raimundo, N., Song, L., Shutt, T. E., McKay, S. E., Cotney, J. L., Guan, M., Gilliland, T., Hohuan, D., Santos‐Sacchi, J., & Shadel, G. S. (2012) · Cell · doi:10.1016/j.cell.2011.12.027 · Cited by 185
Sihto, H. J., Kukko, H., Koljonen, V., Sankila, R. J., Böhling, T., & Joensuu, H. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3363 · Cited by 184
ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance
Millour, J., de Olano, N., Horimoto, Y., Monteiro, L. J., Langer, J. K., Aligué, R., Hajji, N., & Lam, E. W. ‐. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0024 · Cited by 183
Ofir, M., Hacohen, D., & Ginsberg, D. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0344 · Cited by 190
Self-citationSchvartzman, J.-M., Duijf, P. H. G., Sotillo, R., Coker, C., & Benezra, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.017 · Cited by 181
let‐7 and miR‐17‐92: Small‐sized major players in lung cancer development
Osada, H., & Takahashi, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01707.x · Cited by 183
Cell Cycle Regulation During Viral Infection
Bagga, S., & Bouchard, M. J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_10 · Cited by 187
Nikulenkov, F., Spinnler, C., Li, H., Tonelli, C., Shi, Y., Turunen, M. M., Kivioja, T., Ignatiev, I., Kel, A. E., Taipale, J., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.89 · Cited by 181
The SnRK1 Energy Sensor in Plant Biotic Interactions
Hulsmans, S., Rodríguez, M., Coninck, B. D., & Rolland, F. (2016) · Trends in Plant Science · doi:10.1016/j.tplants.2016.04.008 · Cited by 176
The Transcription Factor FOXM1 (Forkhead box M1)
Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407173-5.00004-2 · Cited by 180
Oncosuppressive role of p53‐induced miR‐205 in triple negative breast cancer
Piovan, C., Palmieri, D., Leva, G. D., Braccioli, L., Casalini, P., Nuovo, G. J., Tortoreto, M., Sasso, M., Plantamura, I., Triulzi, T., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.03.003 · Cited by 166
Fournier, N. M., Lee, B., Banasr, M., Elsayed, M., & Duman, R. S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.033 · Cited by 167
RB1 dual role in proliferation and apoptosis: Cell fate control and implications for cancer therapy
Indovina, P., Pentimalli, F., Casini, N., Vocca, I., & Giordano, A. (2015) · Oncotarget · doi:10.18632/oncotarget.4286 · Cited by 165
Motterle, A., Pu, X., Wood, H., Xiao, Q., Gor, S., Liang Ng, F., Chan, K., Cross, F., Shohreh, B., Poston, R. N., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds224 · Cited by 160
Stearoyl CoA desaturase-1: New insights into a central regulator of cancer metabolism
Igal, R. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.009 · Cited by 166
Hill, E. W., McGivney, B. A., Gu, J., Whiston, R., & MacHugh, D. E. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-552 · Cited by 161
miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma
Cai, C., ZHAO, G.-Y., Tian, L., LIU, L., YAN, K., Ma, Y., Ji, Z., Li, X., Han, K., Gao, J., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.1995 · Cited by 147
Adenovirus DNA ReplicationPreprint
Hoeben, R. C., & Uil, T. G. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a013003 · Cited by 144
Ribosomal Proteins Control or Bypass p53 during Nucleolar Stress
Russo, A., & Russo, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010140 · Cited by 155
Role of Cell Cycle Re-Entry in Neurons: A Common Apoptotic Mechanism of Neuronal Cell Death
Folch, J., Junyent, F., Verdaguer, E., Auladell, C., Pizarro, J. G., Beas‐Zárate, C., Pallàs, M., & Camins, A. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9277-4 · Cited by 144
Laine, A., Sihto, H., Come, C., Rosenfeldt, M. T., Zwolinska, A., Niemelä, M., Khanna, A., Chan, E. K., Kähäri, V.-M., Kellokumpu-Lehtinen, P.-L., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0292 · Cited by 130
Wang, S., Gu, Y., Zebell, S. G., Anderson, L. K., Wang, W., Mohan, R., & Dong, X. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.10.005 · Cited by 125
Identifying disease genes and module biomarkers by differential interactions
Liu, X., Liu, Z.-P., Zhao, X., & Chen, L. (2011) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000658 · Cited by 118
Ohtsuka, M., Ling, H. Y., Ivan, C., Pichler, M., Matsushita, D., Goblirsch, M. J., Stiegelbauer, V., Shigeyasu, K., Zhang, X., Chen, M., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.026 · Cited by 113
Recent trends in targeting miRNAs for cancer therapy
Shah, V., & Shah, J. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13351 · Cited by 116
Chopra, M., & Schrenk, D. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2010.524635 · Cited by 114
Seo, H., Choi, H., Kim, S.-R., Choi, Y. K., Woo, S., Shin, I., Woo, J. K., Park, S., Shin, Y. C., & Ko, S.-K. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1310-2 · Cited by 112
Causes and consequences of nuclear envelope alterations in tumour progression
Bell, E. S., & Lammerding, J. (2016) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2016.06.007 · Cited by 115
The Role of the Apoptotic Machinery in Tumor SuppressionPreprint
Delbridge, A. R. D., Valente, L. J., & Strasser, A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008789 · Cited by 106
Transcriptional and epigenetic regulation of the p53 tumor suppressor gene
Saldaña-Meyer, R., & Targa, F. R. (2011) · Epigenetics · doi:10.4161/epi.6.9.16683 · Cited by 103
Tumor Protein 53-Induced Nuclear Protein 1 Enhances p53 Function and Represses Tumorigenesis
Shahbazi, J., Lock, R. B., & Liu, T. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00080 · Cited by 98
Specific Acetylation of p53 by HDAC Inhibition Prevents DNA Damage-Induced Apoptosis in Neurons
Brochier, C., Dennis, G., Rivieccio, M. A., McLaughlin, K., Coppola, G., Ratan, R. R., & Langley, B. C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5214-12.2013 · Cited by 97
Cho, H., Toyokawa, G., Daigo, Y., Hayami, S., Masuda, K., Ikawa, N., Yamane, Y., Maejima, K., Tsunoda, T., Field, H. I., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26501 · Cited by 97
Cheng, W., Lin, Z., Wei, B.-F., Zeng, Q., Han, B., Wei, C., Xian-jun, F., Hu, C., Liu, L.-H., Huang, J., et al. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.12.013 · Cited by 95
Gao, Y., Chi, Y., Chen, Y., Wang, W., Li, H., Zheng, W., Zhu, P., An, J., Duan, Y., Sun, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39958-5 · Cited by 96
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Chowdhury, S., Kennedy, J. J., Ivey, R. G., Murillo, O. D., Hosseini, N., Song, X., Petralia, F., Calinawan, A. P., Savage, S. R., Berry, A. B., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.004 · Cited by 95
PERK Integrates Oncogenic Signaling and Cell Survival During Cancer Development
Bu, Y., & Diehl, J. A. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25336 · Cited by 92
Inferring transcriptional and microRNA‐mediated regulatory programs in glioblastoma
Setty, M. N., Helmy, K. Y., Khan, A. A., Silber, J., Arvey, A. J., Neezen, F., Agius, P., Huse, J. T., Holland, E. C., & Leslie, C. S. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.37 · Cited by 89
Dennis, S., Sheth, U., Feldman, J. L., English, K. A., & Priess, J. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002591 · Cited by 88
Transcriptional Regulation of Energy Metabolism in Cancer Cells
Rodríguez‐Enríquez, S., Marín‐Hernández, Á., Gallardo‐Pérez, J. C., Pacheco-Velázquez, S. C., Belmont-Díaz, J., Robledo‐Cadena, D. X., Vargas-Navarro, J. L., de la Peña, N. A. C., Saavedra, E., & Moreno‐Sánchez, R. (2019) · Cells · doi:10.3390/cells8101225 · Cited by 88
Effects of TP53 mutational status on gene expression patterns across 10 human cancer types
Parikh, N., Hilsenbeck, S. G., Creighton, C. J., Dayaram, T., Shuck, R. L., Shinbrot, E., Liu, X., Gibbs, R. A., Wheeler, D. A., & Donehower, L. A. (2013) · The Journal of Pathology · doi:10.1002/path.4321 · Cited by 91
Going out of the brain: Non-nervous system physiological and pathological functions of Cdk5
Contreras-Vallejos, E., Utreras, E., & González-Billault, C. E. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.08.022 · Cited by 92
Pallis, A. G., Hatse, S., Brouwers, B. A. H., Pawelec, G., Falandry, C., Wedding, U., Lago, L. D., Repetto, L., Ring, A. E., & Wildiers, H. P. M. W. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2013.09.001 · Cited by 84
E2F1 apoptosis counterattacked: evil strikes back
Pützer, B. M., & Engelmann, D. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.10.009 · Cited by 88
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status
Yang, G., Zhang, R., Chen, X., Mu, Y., Ai, J., Chen, S., Liu, Y., Shi, C., Sun, L., Rainov, N. G., et al. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0775-x · Cited by 83
The PI3K/Akt/mTOR pathway regulates the replicative senescence of human VSMCs
Tan, P., Wang, Y., Li, S., Wang, Y., He, J., Chen, Y., Deng, H., Huang, W., Zhan, J., & Liu, Y. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2796-9 · Cited by 80
Emerging Role of the Nucleolar Stress Response in Autophagy
Pfister, A. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00156 · Cited by 83
Carrière, C., Gore, A. J., Norris, A. M., Gunn, J. R., Young, A. L., Longnecker, D. S., & Korc, M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.041 · Cited by 76
Smyd3-associated regulatory pathways in cancer
Giakountis, A., Moulos, P., Sarris, M. E., Hatzis, P., & Talianidis, I. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.08.008 · Cited by 76
Modeling epigenetic lesions that cause gliomas
Rahme, G. J., Javed, N. M., Puorro, K. L., Xin, S., Hovestadt, V., Johnstone, S. E., & Bernstein, B. (2023) · Cell · doi:10.1016/j.cell.2023.06.022 · Cited by 75
Zhan, W., Wang, W., Han, T., Xie, C., Zhang, T., Gan, M., & Wang, J.-B. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.11.016 · Cited by 72
Complex Cartography: Regulation of E2F Transcription Factors by Cyclin F and Ubiquitin
Emanuele, M. J., Enrico, T. P., Mouery, R. D., Wasserman, D., Nachum, S., & Tzur, A. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.05.002 · Cited by 72
miR-34a Induces the Downregulation of Both E2F1 and B-Myb Oncogenes in Leukemic Cells
Zauli, G., Voltan, R., di Iasio, M. G., Bosco, R., Melloni, E., Sana, M. E., & Secchiero, P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3244 · Cited by 74
The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage
Feldstein, O., Nizri, T., Doniger, T., Jacob, J., Rechavi, G., & Ginsberg, D. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-131 · Cited by 72
Self-citationNovel insights into RB1 mutation
Yao, Y., Gu, X., Xu, X., Ge, S., & Jia, R. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215870 · Cited by 72
Fu, J., Lv, H., Guan, H., Ma, X., Ji, M., He, N., Shi, B., & Hou, P. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-462 · Cited by 70
Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer
Thurlings, I., Martínez-López, L. M., Westendorp, B., Zijp, M., Kuiper, R., Tooten, P. C. J., Kent, L. N., Leone, G. W., Vos, H. R., Burgering, B. M. T., et al. (2016) · Oncogene · doi:10.1038/onc.2016.251 · Cited by 71
Redundancy: A Critical Obstacle to Improving Cancer Therapy
Lavi, O. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3256 · Cited by 74
E2F1: Cause and Consequence of DNA Replication Stress
Fouad, S., Hauton, D., & D’Angiolella, V. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.599332 · Cited by 67
Revisiting the Female Germline and Its Expanding Toolbox
Pinto, S. C., Mendes, M. A., Coimbra, S., & Tucker, M. R. (2019) · Trends in Plant Science · doi:10.1016/j.tplants.2019.02.003 · Cited by 66
Hasei, J., Sasaki, T., Tazawa, H., Osaki, S., Yamakawa, Y., Kunisada, T., Yoshida, A., Hashimoto, Y., Onishi, T., Uno, F., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0869 · Cited by 70
Engelmann, D., & Pützer, B. M. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.06.001 · Cited by 69
Tovy, A., Spiro, A., McCarthy, R. L., Shipony, Z., Aylon, Y., Allton, K. L., Ainbinder, E., Furth, N., Tanay, A., Barton, M. C., et al. (2017) · Genes & Development · doi:10.1101/gad.299198.117 · Cited by 64
Bysani, M., Perfilyev, A., de Mello, V. D., Rönn, T., Nilsson, E., Pihlajamäki, J., & Ling, C. (2016) · Epigenomics · doi:10.2217/epi-2016-0087 · Cited by 67
Zhang, L., Ruan, J., Yan, L., Li, W., Wu, Y. C., Li, T., Zhang, F., Zheng, S., Wang, A., & Lu, Y. (2012) · Molecules · doi:10.3390/molecules17043736 · Cited by 62
Udayakumar, T. S., Shareef, M. M., Diaz, D. A., Ahmed, M. M., & Pollack, A. S. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.05.007 · Cited by 62
Starvation, detoxification, and multidrug resistance in cancer therapy
Lee, C. D., Raffaghello, L., & Longo, V. D. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.004 · Cited by 64
Xiao, D., Huang, J. X., Pan, Y., Li, H. R., Fu, C., Mao, C., Cheng, Y., Shi, Y., Chen, L., Jiang, Y., et al. (2016) · Theranostics · doi:10.7150/thno.17032 · Cited by 62
PARP‐1 regulates DNA repair factor availability
Schiewer, M. J., Mandigo, A. C., Gordon, N., Huang, F., Gaur, S., de Leeuw, R., Zhao, S. G., Evans, J. R., Han, S., Parsons, T., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708816 · Cited by 63
Kinnaird, J. H., Weir, W., Durrani, Z., Pillai, S. S., Baird, M., & Shiels, B. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066833 · Cited by 62
Anderson, M. E., Randall, R. L., Springfield, D. S., & Gebhardt, M. C. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00092-8 · Cited by 59
Hsu, W., Zhao, X., Zhu, J., Kim, I., Rao, G., McCutcheon, J. N., Hsu, S.-T., Teicher, B. A., Kallakury, B., Dowlati, A., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.01.028 · Cited by 59
Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer
Regouc, M., Belge, G., Lorch, A., Dieckmann, K., & Pichler, M. (2020) · Cancers · doi:10.3390/cancers12030749 · Cited by 58
The dual role of p53: DNA protection and antioxidant
Borrás, C., Gómez‐Cabrera, M. C., & Viña, J. (2011) · Free Radical Research · doi:10.3109/10715762.2011.571685 · Cited by 58
KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress
Lezina, L., Aksenova, V., Ivanova, T., Purmessur, N. S., Antonov, A. V., Tentler, D., Fedorova, O., Garabadgiu, A. V., Talianidis, I., Melino, G., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.108 · Cited by 58
Ramaiah, M. J., Lavanya, A., Honarpisheh, M. M., Zarea, M., Bhadra, U., & Bhadra, M. P. (2014) · Gene · doi:10.1016/j.gene.2014.09.052 · Cited by 57
Vera, J., Schmitz, U., Lai, X., Engelmann, D., Khan, F. M., Wolkenhauer, O., & Pützer, B. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4095 · Cited by 57
Metadata
- Authors
- Polager, S., & Ginsberg, D.
- Affiliations
- Bar-Ilan University (IL)
- Corresponding author
- Ginsberg, Doron
- ORCID
- Ginsberg, Doron
- Venue
- Nature Reviews Cancer
- Published
- 2009-10
- Volume
- 9
- Issue
- 10
- Pages
- 738-748
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2019562165
- Cited by
- 498
- References
- 136
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 20 · 2023: 23 · 2022: 13 · 2021: 23 · 2020: 18 · 2019: 23 · 2018: 27 · 2017: 35 · 2016: 38 · 2015: 41 · 2014: 43 · 2013: 54 · 2012: 46
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, E2F1, Rb/E2F pathway, MDM2-p53 pathway, pathway crosstalk, cell cycle regulation, cell fate, carcinogenesis, transcription factors, tumor suppressor
- MeSH terms
- Cell Cycle, Cell Survival, Humans, Mutation, Neoplasms, Signal Transduction, Tumor Suppressor Protein p53, Apoptosis, Cell Proliferation, E2F Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review